USPTO serial 86890989
GENEFORGE
Reviewed by CopyMark Law Group
Reg. 5456122Status 710
- Filing date
- Status date
- Registration date
- May 1, 2018
- Examiner
- BEDNARZ, DUSTIN THOMAS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with GENEFORGE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Oxford Nanopore Technologies Limited
Oxford, GB
Other trademarks owned by Oxford Nanopore Technologies Limited
Oxford Nanopore Technologies Limited
Oxford, GB
Other trademarks owned by Oxford Nanopore Technologies Limited
Oxford Nanopore Technologies Limited
Oxford, GB
Other trademarks owned by Oxford Nanopore Technologies Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210-2206UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Deoxyribonucleic acid, single stranded and double stranded deoxyribonucleic acid; ribonucleic acid; peptide nucleic acids; nucleic acids; oligonucleotides; peptides for industrial purposes and scientific research purposes; nucleotides, pyrimidines, purines for use in analytical tests for scientific and research purposes; chemicals for scientific or research use in tests to detect diseases in plant life, other than pesticides; buffer solutions for use in analytical chemistry, biochemistry, biology, biotechnology and genomic experiments and tests; aqueous solvents for scientific and research use; non-aqueous solvents for scientific and research use; silicone oils for use in analytical tests for scientific or research use; silicone fluids; all the aforesaid other than for medical or veterinary purposes; all of the aforesaid for the analysis, synthesis and sequencing of nucleic acid polymers; none of the foregoing including enzymes for the production of biofuels and other products from renewable carbon feedstocks or enzymes for the conversion of cellulosic biomass to sugars and other products | SECTION 8 - CANCELLED | — |
| 005 | Buffer solutions for medical or veterinary purposes; aqueous solvents for medical or veterinary purposes; non-aqueous solvents for medical or veterinary purposes; surfactants for medical and veterinary testing purposes; silicone oils for use in tests for medical and veterinary testing purposes; protein arrays for use in tests for medical or veterinary diagnosis purposes; all of the aforesaid for the analysis, synthesis and sequencing of nucleic acid polymers; none of the foregoing including enzymes for the production of biofuels and other products from renewable carbon feedstocks or enzymes for the conversion of cellulosic biomass to sugars and other products | SECTION 8 - CANCELLED | — |
| 009 | Apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICs (application specific integrated circuits), and networked computer hardware and software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis for scientific or research purposes; scientific apparatus and instruments for sequencing DNA, RNA, protein and polynucleic acid sequencing; scientific apparatus and laboratory devices for the scientific analysis of polynucleic acid sequences; apparatus and instruments for the analysis of nucleic and polynucleic acids for scientific or research purposes;apparatus and instruments for the analysis of nucleic and polynucleic acids, namely, microarrays, and silicon chip based arrays for scientific or research purposes; apparatus and instruments for analysis of genetic information, genomic information and proteomic information, namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICS (application specific integrated circuits), and networked computer hardware and software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis for scientific or research purposes; Computer software programs, computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; scientific apparatus, devices and instruments for synthesising chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides for scientific research and scientific testing purposes; data processing apparatus, devices and instruments; scientific apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides for scientific research and scientific testing purposes; portable computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; computer peripheral devices; electronic display interfaces for the display of information obtained from scientific equipment; silicon chips; DNA chips; microarray chips; analyte detector chips for scientific or research use; biosensor chips for scientific or research use; apparatus and instruments for use in laboratory analysis, namely, empty cartridges for test samples, namely, cartridges for use with concentrates and solutions in solid or liquid form samples for scientific or research testing use; batteries; rechargeable batteries; chargers for batteries; computer docking stations; reaction units containing chemical or biological reagents, namely, reaction systems for scientific or research purposes; scientific testing apparatus, namely, Nanopore sensing devices; parts and fittings for all the aforesaid goods | SECTION 8 - CANCELLED | — |
| 010 | Medical and veterinary diagnostic apparatus and instruments for the testing and analysis of DNA, RNA and other genetic material for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; blood testing apparatus; diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; cartridges for test samples, for medical purposes; reaction units containing chemical reagents, namely, reaction systems for medical testing purposes; Nanopore sensing devices for medical or veterinary purposes; parts and fittings for all the aforesaid goods | SECTION 8 - CANCELLED | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, consultation, research and design services relating to automated systems and instruments for direct electrical detection and analysis of molecules for use in the field of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; industrial research services in the fields of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; scientific research in the fields of biology, chemistry, biochemistry, bacteriology, medicine and veterinary science; biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular analysis services namely, biological, chemical, biochemical, bacteriological DNA, RNA, protein, polynucleic acid and molecular analysis for scientific testing and scientific research purposes; scientific and technological services, namely, synthesizing chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides for scientific purposes and medical research purposes; scientific research for medical or veterinary purposes; DNA and RNA and polynucleic acid sequencing services for scientific research purposes; protein sequencing services for scientific research purposes; design and development of instruments and apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; DNA and polynucleic acid testing services, namely, the analysis of DNA and polynucleic acids for scientific and scientific research purposes; genome sequencing services for scientific testing and scientific research purposes; information and advice regarding all the aforesaid services | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oxford Nanopore Technologies Limited
- Other trademarks owned by Oxford Nanopore Technologies Limited
- Other trademarks owned by Oxford Nanopore Technologies Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named GENEFORGE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 15, 2024 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| May 1, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 1, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 13, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 13, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 24, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 6, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 22, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 22, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 21, 2017 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 6, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 6, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 6, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 6, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 5, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 5, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 30, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 30, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 30, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 9, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 9, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 9, 2016 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 8, 2016 | ALIE | ASSIGNED TO LIE | — |
| Nov 22, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 13, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 13, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 23, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 23, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 23, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 16, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 9, 2016 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Feb 9, 2016 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 4, 2016 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Feb 3, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 2, 2016 | NWAP | NEW APPLICATION ENTERED | — |